Covid-19 antibody tests face a very specific problem
With the prevalence of coronavirus infection running at about 5%, test manufacturers and regulators alike will have to guard against false positives.
FDA authorises the first Covid-19 antibody test
Cellex wins the race to get the FDA’s buy-in for a blood test to pinpoint immunity.